871
Views
0
CrossRef citations to date
0
Altmetric
Cell Biology

Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants

& ORCID Icon
Pages 664-674 | Received 27 Jul 2023, Accepted 09 Nov 2023, Published online: 05 Dec 2023

REFERENCES

  • Majtan T, Pey AL, Ereno-Orbea J, Martinez-Cruz LA, Kraus JP. Targeting cystathionine beta-synthase misfolding in homocystinuria by small ligands: state of the art and future directions. Curr Drug Targets. 2016;17:1455–1470. doi:10.2174/1389450117666160302094910.
  • Majtan T, Kozich V, Kruger WD. Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria. Br J Pharmacol. 2023;180:264–278. doi:10.1111/bph.15991.
  • Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, et al. The natural history of homocystinuria due to cystathionine b-synthase deficiency. Am J Hum Genet. 1985;37:1–31.
  • Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler K, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. New York (NY): McGraw-Hill; 2001. Mudd #172 Reprint Status: In File.
  • Kruger WD. How to fix a broken protein: restoring function to mutant human cystathionine beta-synthase. Hum Genet. 2022;141:1299–1308. doi:10.1007/s00439-021-02386-w.
  • Majtan T, Pey AL, Fernandez R, Fernandez JA, Martinez-Cruz LA, Kraus JP. Domain organization, catalysis and regulation of eukaryotic cystathionine beta-synthases. PloS One. 2014;9:e105290. doi:10.1371/journal.pone.0105290.
  • Pey AL, Majtan T, Sanchez-Ruiz JM, Kraus JP. Human cystathionine beta-synthase (CBS) contains two classes of binding sites for s-adenosylmethionine (SAM):complex regulation of CBS activity and stability by SAM. Biochem J. 2013;449:109–121. doi:10.1042/BJ20120731.
  • Janosik M, Oliveriusova J, Janosikova B, Sokolova J, Kraus E, Kraus JP, Kozich V. Impaired heme binding and aggregation of mutant cystathionine beta-synthase subunits in homocystinuria. Am J Hum Genet. 2001;68:1506–1513. doi:10.1086/320597.
  • Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319:916–919. doi:10.1126/science.1141448.
  • Westerheide SD, Morimoto RI. Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem. 2005;280:33097–33100. doi:10.1074/jbc.R500010200.
  • Suresh B, Lee J, Kim H, Ramakrishna S. Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ. 2016;23:1257–1264. doi:10.1038/cdd.2016.53.
  • Singh LR, Chen X, Kozich V, Kruger WD. Chemical chaperone rescue of mutant human cystathionine beta-synthase. Mol Genet Metab. 2007;91:335–342. doi:10.1016/j.ymgme.2007.04.011.
  • Singh LR, Kruger WD. Functional rescue of mutant human cystathionine beta-synthase by manipulation of hsp26 and hsp70 levels in saccharomyces cerevisiae. J Biol Chem. 2009;284:4238–4245. doi:10.1074/jbc.M806387200.
  • Majtan T, Liu L, Carpenter JF, Kraus JP. Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes. J Biol Chem. 2010;285:15866–15873. doi:10.1074/jbc.M110.107722.
  • Singh LR, Gupta S, Honig NH, Kraus JP, Kruger WD. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PloS Genet. 2010;6:e1000807. doi:10.1371/journal.pgen.1000807.
  • Kopecka J, Krijt J, Rakova K, Kozich V. Restoring assembly and activity of cystathionine beta-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis. 2011;34:39–48. doi:10.1007/s10545-010-9087-5.
  • Bernier V, Lagace M, Bichet DG, Bouvier M. Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol Metab. 2004;15:222–228. doi:10.1016/j.tem.2004.05.003.
  • Barber GW, Spaeth GL. The successful treatment of homocystinuria with pyridoxine. J Pediatr. 1969;75:463–478. doi:10.1016/s0022-3476(69)80274-x.
  • Kozich V, Sokolova J, Morris AAM, Pavlikova M, Gleich F, Kolker S, Krijt J, Dionisi-Vici C, Baumgartner MR, Blom HJ, et al. Cystathionine beta-synthase deficiency in the e-hod registry-part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis. J Inherit Metab Dis. 2021;44:677–692. doi:10.1002/jimd.12338.
  • Majtan T, Singh LR, Wang L, Kruger WD, Kraus JP. Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone. J Biol Chem. 2008;283:34588–34595. doi:10.1074/jbc.M805928200.
  • Melenovska P, Kopecka J, Krijt J, Hnizda A, Rakova K, Janosik M, Wilcken B, Kozich V. Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate. J Inherit Metab Dis. 2015;38:287–294. doi:10.1007/s10545-014-9781-9.
  • Kozich V, Sokolova J, Klatovska V, Krijt J, Janosik M, Jelinek K, Kraus JP. Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity. Hum Mutat. 2010;31:809–819. doi:10.1002/humu.21273.
  • Majtan T, Pey AL, Kraus JP. Kinetic stability of cystathionine beta-synthase can be modulated by structural analogs of s-adenosylmethionine: potential approach to pharmacological chaperone therapy for homocystinuria. Biochimie. 2016;126:6–13. doi:10.1016/j.biochi.2016.01.009.
  • Fricker LD. Proteasome inhibitor drugs. Annu Rev Pharmacol Toxicol. 2020;60:457–476. doi:10.1146/annurev-pharmtox-010919-023603.
  • Gupta S, Wang L, Anderl J, Slifker MJ, Kirk C, Kruger WD. Correction of cystathionine beta-synthase deficiency in mice by treatment with proteasome inhibitors. Hum Mutat. 2013;34:1085–1093. doi:10.1002/humu.22335.
  • Gupta S, Wang L, Kruger WD. The c.797 g > a (p.R266k) cystathionine beta-synthase mutation causes homocystinuria by affecting protein stability. Hum Mutat. 2017;38:863–869. doi:10.1002/humu.23240.
  • Gupta S, Gallego-Villar L, Wang L, Lee HO, Nasrallah G, Al-Dewik N, Haberle J, Thony B, Blom HJ, Ben-Omran T, et al. Analysis of the qatari r336c cystathionine beta-synthase protein in mice. J Inherit Metab Dis. 2019;42:831–838. doi:10.1002/jimd.12140.
  • Gupta S, Lee HO, Wang L, Kruger WD. Examination of two different proteasome inhibitors in reactivating mutant human cystathionine beta-synthase in mice. PloS One. 2023;18:e0286550. doi:10.1371/journal.pone.0286550.
  • Cristofani R, Piccolella M, Crippa V, Tedesco B, Montagnani Marelli M, Poletti A, Moretti RM. The role of HSPB8, a component of the chaperone-assisted selective autophagy machinery, in cancer. Cells. 2021;10:335. doi:10.3390/cells10020335.
  • Carra S, Seguin SJ, Landry J. Hspb8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 2008;4:237–239. doi:10.4161/auto.5407.
  • Tedesco B, Cristofani R, Ferrari V, Cozzi M, Rusmini P, Casarotto E, Chierichetti M, Mina F, Galbiati M, Piccolella M, et al. Insights on human small heat shock proteins and their alterations in diseases. Front Mol Biosci. 2022;9:842149. doi:10.3389/fmolb.2022.842149.
  • Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 2002;295:1852–1858. doi:10.1126/science.1068408.
  • Qiu XB, Shao YM, Miao S, Wang L. The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci. 2006;63:2560–2570. doi:10.1007/s00018-006-6192-6.
  • Cyr DM, Hebert DN. Protein quality control–linking the unfolded protein response to disease. Conference on ‘From unfolded proteins in the endoplasmic reticulum to disease’. EMBO Rep. 2009;10:1206–1210. doi:10.1038/embor.2009.224.
  • Casique L, Kabil O, Banerjee R, Martinez JC, De Lucca M. Characterization of two pathogenic mutations in cystathionine beta-synthase: different intracellular locations for wild-type and mutant proteins. Gene. 2013;531:117–124. doi:10.1016/j.gene.2013.08.021.
  • Mozos A, Roue G, Lopez-Guillermo A, Jares P, Campo E, Colomer D, Martinez A. The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma. Am J Pathol. 2011;179:2601–2610. doi:10.1016/j.ajpath.2011.07.031.
  • Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263–1273. doi:10.1172/JCI11596.
  • Martinez-Pizarro A, Desviat LR, Ugarte M, Perez B, Richard E. Endoplasmic reticulum stress and autophagy in homocystinuria patients with remethylation defects. PloS One. 2016;11:e0150357. doi:10.1371/journal.pone.0150357.
  • Maclean KN, Gaustadnes M, Oliveriusova J, Janosik M, Kraus E, Kozich V, Kery V, Skovby F, Rudiger N, Ingerslev J, et al. High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations. Hum Mutat. 2002;19:641–655. doi:10.1002/humu.10089.
  • Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, Lubonja R, Thomas SR, Alkan O, Bhimdi T, et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods. 2011;8:659–661. doi:10.1038/nmeth.1638.